- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Sobngwi Eugene
Total 1762 results
-
Washington University School of MedicineCelgene CorporationCompleted
-
University of Southern CaliforniaAstraZeneca; Celgene CorporationCompleted
-
Oregon Health and Science UniversityCelgene CorporationTerminated
-
MD Anderson International Spain SACelgene CorporationCompletedChronic Lymphocytic LeukemiaSpain
-
University of California, San FranciscoCelgene CorporationCompletedAdenocarcinoma | Pancreatic Neoplasms | Pancreatic CancerUnited States
-
Chronic Lymphocytic Leukemia Research ConsortiumCelgene CorporationUnknownChronic Lymphocytic Leukemia | CLL | Untreated | First-Line | Front-line | Initial TherapyUnited States
-
Libella Gene TherapeuticsUnknownAlzheimer DiseaseColombia
-
Evgen PharmaPremier Research Group plcCompletedBreast NeoplasmUnited Kingdom, Belgium, France, Spain
-
Canadian Urology Research ConsortiumOICR; EigenUnknown
-
IRCCS Eugenio MedeaCNR - ICMATE UOS di LeccoRecruitingAcquired Brain InjuryItaly
-
University of LeedsTakeda; Cancer Research UK; CelgeneRecruitingMultiple MyelomaUnited Kingdom
-
Ohio State University Comprehensive Cancer CenterCelgene CorporationRecruitingCutaneous T-cell Lymphoma | Peripheral T-Cell Lymphoma | T-Prolymphocytic Leukemia | T-Large Granulocytic Leukemia | T-Lymphoblastic Leukemia/LymphomaUnited States
-
Fox Chase Cancer CenterCelgene Corporation; Seagen Inc.Active, not recruitingCutaneous T-cell Lymphoma (CTCL)United States
-
Institut de Recherches Internationales ServierCelgene CorporationActive, not recruitingUntreated AML | Newly Diagnosed Acute Myeloid Leukemia (AML) | AML Arising From Myelodysplastic Syndrome (MDS) | AML Arising From Antecedent Hematologic Disorder (AHD) | AML Arising After Exposure to Genotoxic InjuryUnited States, Germany, Netherlands
-
Joseph TuscanoTakeda; CelgeneActive, not recruiting
-
IRCCS Eugenio MedeaUniversity of Rome Tor VergataCompleted
-
Maria LiljeforsKarolinska University Hospital; Karolinska Institutet; CelgeneCompletedPancreatic Ductal Adenocarcinoma | Pancreatic Carcinoma MetastaticSweden
-
Emory UniversityMerck Sharp & Dohme LLC; Celgene CorporationCompleted
-
Weill Medical College of Cornell UniversityCelgene CorporationCompletedMultiple MyelomaUnited States
-
Royal Marsden NHS Foundation TrustBoehringer Ingelheim; CelgeneWithdrawnAdenocarcinoma of Lung | NSCLC, Recurrent
-
Sunnybrook Health Sciences CentreCelgene; Sunnybrook Research InstituteWithdrawn
-
M.D. Anderson Cancer CenterCelgene; Onyx Therapeutics, Inc.Terminated
-
Icahn School of Medicine at Mount SinaiCelgeneCompleted
-
University of California, San DiegoPfizer; Celgene CorporationCompletedAcute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterNovartis Pharmaceuticals; Celgene CorporationCompleted
-
Jun ZhangBaylor College of Medicine; Celgene CorporationTerminatedCarcinoma, Non-Small-Cell LungUnited States
-
Masonic Cancer Center, University of MinnesotaCelgene CorporationTerminatedOvarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity CancerUnited States
-
National University Hospital, SingaporeCelgene; International Myeloma FoundationUnknownRelapse Multiple MyelomaSingapore, Hong Kong, Japan, Korea, Republic of, Taiwan
-
SCRI Development Innovations, LLCMillennium Pharmaceuticals, Inc.; CelgeneCompleted
-
Medical University of South CarolinaGlaxoSmithKline; Celgene CorporationCompletedChronic Lymphocytic LeukemiaUnited States
-
University of Michigan Rogel Cancer CenterCelgene CorporationCompletedBladder CancerUnited States
-
Kenneth Peters, MDCelgene CorporationCompletedProstatitis | Chronic Prostatitis With Chronic Pelvic Pain SyndromeUnited States
-
Arbeitsgemeinschaft medikamentoese TumortherapieRoche Pharma AG; Celgene CorporationCompletedLeukemia, Lymphocytic, Chronic, B-CellAustria
-
Kenneth Peters, MDCelgene Corporation; William Beaumont HospitalsTerminatedPelvic Pain | Chronic ProstatitisUnited States
-
Celgene CorporationCompletedHIV Infections | HIV Wasting SyndromeUnited States
-
IRCCS Eugenio MedeaUniversità degli studi di BergamoRecruiting
-
Chinese PLA General HospitalPeking University; EdiGene Inc.RecruitingNon Hodgkin's LymphomaChina
-
RenJi HospitalBeiGene; Huidu Shanghai Medical Sciences LtdRecruitingUrologic Neoplasms | Urogenital Neoplasms | Urinary Bladder Diseases | Urinary Bladder Neoplasms | Antineoplastic Agents | Tislelizumab Antineoplastic Agents, ImmunologicalChina
-
University of LeedsCelgene; Janssen, LP; Myeloma UKActive, not recruiting
-
Massachusetts General HospitalMillennium Pharmaceuticals, Inc.; Celgene CorporationActive, not recruitingAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited States
-
Dana-Farber Cancer InstituteMillennium Pharmaceuticals, Inc.; CelgeneActive, not recruiting
-
Dana-Farber Cancer InstituteCelgene; Secura Bio, Inc.TerminatedPediatric Cancer | Diffuse Intrinsic Pontine Glioma | Pediatric Brain Tumor | Diffuse Glioma | Pediatric Brainstem Glioma | Pediatric Brainstem Gliosarcoma, RecurrentUnited States
-
Ohio State UniversityUniversity of Michigan; Celgene CorporationTerminatedDemyelinating Sensorimotor NeuropathyUnited States
-
Weill Medical College of Cornell UniversityCelgene CorporationTerminated
-
Jonsson Comprehensive Cancer CenterBeiGene; Driven To CureWithdrawnMetastatic Renal Cell Carcinoma | Stage IV Renal Cell Cancer AJCC v8 | Papillary Renal Cell Carcinoma | Collecting Duct Carcinoma | Unresectable Renal Cell Carcinoma | Hereditary Leiomyomatosis and Renal Cell Carcinoma | Clear Cell Papillary Renal Neoplasm | Hereditary Papillary Renal Cell Carcinoma and other conditionsUnited States
-
The Methodist Hospital Research InstituteNovartis; Celgene CorporationCompletedBreast CancerUnited States
-
German Breast GroupRoche Pharma AG; Celgene CorporationCompletedInflammatory Breast Cancer | HER-2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage III | Inflammatory Breast Cancer Stage IVGermany
-
Jonsson Comprehensive Cancer CenterCelgene Corporation; CTI BioPharmaTerminatedMyelodysplastic Syndromes | LeukemiaUnited States
-
University of Wisconsin, MadisonGenentech, Inc.; Celgene CorporationWithdrawnChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL)
-
Icahn School of Medicine at Mount SinaiCelgeneTerminatedUrinary Bladder NeoplasmsUnited States